Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease.

Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease.
复制标题

为患有镰状细胞病的幼儿进行羟基脲试验,开发基于风险的复合神经学结果。

DOI:
10.1177/1740774518807160
复制
发表时间:
2019
期刊:
Clinical trials (London, England)
影响因子:
--
通讯作者:
Lehmann,HaroldP
Lehmann,HaroldP
中科院分区:
--
文献类型:
--
作者:
Casella,JamesF;Adams,RobertJ;Brambilla,DonaldJ;Strouse,JohnJ;Maier,Pia;Dlugash,Rachel;Avadhani,Radhika;Vermillion,Krista;Tonascia,James;Voeks,JeniferH;Hanley,DanielF;Thompson,RichardE;Lehmann,HaroldP

文献摘要

相似文献